SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001564590-20-017915
Filing Date
2020-04-22
Accepted
2020-04-22 16:10:20
Documents
1
Effectiveness Date
2020-04-22

Document Format Files

Seq Description Document Type Size
1 DEFA14A fprx-defa14a_20200514.htm DEFA14A 39095
  Complete submission text file 0001564590-20-017915.txt   40212
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36070 | Film No.: 20808061
SIC: 2834 Pharmaceutical Preparations